Metabolic syndrome in patients with systemic lupus erythematosus
Objective. To characterize metabolic syndrome (M S) in pts wit h systemic lupus erythematosus (SLE) and determine contribution of immune inflammation to the development of MS. Material and methods. 156 females with SLE (mean age 35 years, mean disease duration 99 months) were included. Control group...
Main Authors: | T Y Popkova, D S Novikova, E. V. Gerasimova, E N Alexandrova, A A Novikov, E S Maeh, S. S. Alekberova, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2008-08-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/668 |
Similar Items
-
Role of inflammation in the development of cardiac autonomic disfunction in patients with systemic lupus erythematosus
by: D. S. Novikova, et al.
Published: (2008-12-01) -
Atherogenic effect of systemic lupus erythematosus pts blood serum
by: Z S Alekberova, et al.
Published: (2003-06-01) -
Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
by: T V Popkova, et al.
Published: (2008-05-01) -
Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
by: T A Panafidina, et al.
Published: (2008-05-01) -
Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus
by: Z. S. Alekberova, et al.
Published: (2016-05-01)